9Mandema JW,Kaieo RF,Oshlack B,et al.Characterization and validation of a pharmacokinetic model for controlled -release oxycodone.[J].Br J Clin Pharmacol,1996,42(6):747 -756
6Yawn BP, Saddier P, Wollm PC, et al. A population--based study of the in- cidence and complication rates of herpes zoster betore zoster vaccine intro- duction[ J]. Mayo Clin Proc ,2007,82 ( 11 ) : 1341-1349.
7Kaplan R, Winston C, Parris V, et al. Comparison of controlled release and immediate-release oxycodone tablets in patients with cancer pain[ J]. J Clin Onc, 1998,16:3230-3237.
8Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock , curt- trolled-release oxycodone therapy for osteoarthritis-related pain. Arch Intern Med 2000; 160:853-860.
9Wasaburo Koizumiet al: Efficacy and Tolerability of Cancer Pain Manage- ment with Controlled-release Oxycodone Tablets in Opioidnfffve Cancer Pain Patients, Starting with 5 mg Tablets[ J ]. Jpn J Clin Oncol, 2004,34(10) : 608-614.
10Barrera-Chacon JM, Mendez-Suarez JL, Jregui-Abrisqueta ML, et al. oxyc- odone improves pain control and quality of life in anticonvul-sant-pretreated spinal eord-injured patients with neuropathic pain[ J]. Spinal cord ,2011,49(1):36-42.
